ストックスクリーナーアプリを入手
4.71
0.43%
0.02
前日終値:
$4.69
開ける：
$4.68
24時間の取引高:
479.94K
Relative Volume:
0.53
時価総額：
$322.26M
収益：
-
当期純損益:
$-96.66M
株価収益率:
-2.1907
EPS:
-2.15
ネットキャッシュフロー:
$-83.73M
1週間 パフォーマンス:
+2.39%
1か月 パフォーマンス:
+10.56%
6か月 パフォーマンス:
-48.64%
1年 パフォーマンス:
-51.24%
1日の値動き範囲:
$4.56
$4.78
1週間の範囲:
$4.06
$5.08
52週間の値動き範囲:
$2.86
$16.62
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
OLMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
4.71 | 314.46M | 0 | -96.66M | -83.73M | -2.15 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2024-01-30 | 開始されました | Citigroup | Buy |
| 2023-07-21 | 開始されました | Oppenheimer | Outperform |
| 2023-05-05 | 開始されました | CapitalOne | Overweight |
| 2023-02-22 | 開始されました | Credit Suisse | Outperform |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | Canaccord Genuity | Buy |
| 2020-12-14 | 開始されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | JP Morgan | Overweight |
| 2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
The Goldman Sachs Group Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $18.00 - Defense World
Oppenheimer Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $22.00 - Defense World
Q2 EPS Estimate for Olema Pharmaceuticals Raised by Analyst - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Acquired by MPM Bioimpact LLC - MarketBeat
Paradigm Biocapital Advisors LP Buys 1,801,370 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Voya Investment Management LLC Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Driehaus Capital Management LLC Takes $1.28 Million Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth - Yahoo Finance
Olema Pharmaceuticals (OLMA) Price Target Lowered by Oppenheimer - GuruFocus
Balyasny Asset Management L.P. Increases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals (OLMA) Price Target Lowered by Goldman Sachs | OLMA Stock News - GuruFocus
Olema Oncology (OLMA) Price Target Adjusted Amid Upcoming Data R - GuruFocus
Lightspeed Management Company L.L.C. Makes New Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Oncology (OLMA) Pushes Forward with Promising Cancer Treat - GuruFocus
Olema Oncology (OLMA) Pushes Forward with Promising Cancer Treatments | OLMA Stock News - GuruFocus
Olema Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Olema Oncology Reports First Quarter 2025 Financial and Operating Results - GlobeNewswire
Olema Oncology Strengthens Breast Cancer Pipeline: Key Phase 3 Trial Updates and $392M War Chest - Stock Titan
Hsbc Holdings PLC Invests $58,000 in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals (OLMA) Projected to Post Earnings on Wednesday - MarketBeat
Deep Track Capital LP Decreases Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Dimensional Fund Advisors LP Cuts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Wells Fargo & Company MN Raises Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology to Participate in Upcoming Investor Conferences | - GuruFocus
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by BVF Inc. IL - MarketBeat
Olema Oncology to Participate in Upcoming Investor Conferences - GlobeNewswire
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Barclays PLC - Defense World
Boxer Capital Management LLC Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Market Insight: Olema Pharmaceuticals Inc (OLMA)’s Notable Drop, Closing at 4.60 - DWinneX
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Acquired by Renaissance Technologies LLC - MarketBeat
HC Wainwright Reaffirms Buy Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OLMA Stock News - GuruFocus
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Breast Cancer Drug Developer Olema Awards 104,400 Stock Options to Key New Hires - Stock Titan
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Legal & General Group Plc - Defense World
A look into Olema Pharmaceuticals Inc (OLMA)’s deeper side - Sete News
Renaissance Technologies LLC Has $917,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight - GlobeNewswire Inc.
Can you now get a good deal on Olema Pharmaceuticals Inc’s shares? - uspostnews.com
HC Wainwright Reaffirms “Buy” Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - The AM Reporter
Walleye Capital LLC Invests $391,000 in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
Olema Pharmaceuticals Inc (OLMA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Graham G. Walmsley | Director |
Dec 17 '24 |
Sale |
6.75 |
700,761 |
4,730,137 |
0 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER |
Dec 16 '24 |
Option Exercise |
4.87 |
14,000 |
68,180 |
129,509 |
1.54%
7.58%
大文字化:
|
ボリューム (24 時間):